Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments
Awakn Life Sciences (AWKN) received approval to begin ketamine treatments for mental health and addiction at its third clinic, located in London. The company also has ketamine clinics in Bristol, UK and Oslo, Norway.
